Delivery Order SPE2DB22D2211-SPE2DB25FSEAK
Award Date 9/2/25
Potential Completion Date 9/3/25
Potential Value $42K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $33,849.19 delivery order for Wezlana 90 mg/ml syringes, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $30,488.88 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes. The contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, utilizes firm fixed price pricing with no set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $15,801.47 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $11,343.96 to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes, with a completion date of August 8, 2025. This competitive award (no set-aside used) was issued on August 7, 2025, under a firm fixed price contract type. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations as a major pharmaceutical distributor supporting...
- The Defense Logistics Agency awarded a delivery order valued at $18,464.61 to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes, with an ultimate completion date of August 26, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $53,626.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes on September 2, 2025, with completion targeted for September 3, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $73,246.58 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes, with a completion date of July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded on July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $17,011.92 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Wezlana 90 mg/ml syringes. This firm fixed price contract, with an ultimate completion date of July 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation...
- The Defense Logistics Agency awarded a $13,626.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,540.76 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. This competitive delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed pricing and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal...